{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:20:07Z","timestamp":1760898007792},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,3,28]],"date-time":"2010-03-28T00:00:00Z","timestamp":1269734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00011-010-0185-5","type":"journal-article","created":{"date-parts":[[2010,3,26]],"date-time":"2010-03-26T22:51:34Z","timestamp":1269643894000},"page":"743-753","source":"Crossref","is-referenced-by-count":8,"title":["The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment"],"prefix":"10.1007","volume":"59","author":[{"given":"Manuel","family":"Lima-Rodrigues","sequence":"first","affiliation":[]},{"given":"Nuno","family":"Lamas","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Valle-Fernandes","sequence":"additional","affiliation":[]},{"given":"Andrea","family":"Cruz","sequence":"additional","affiliation":[]},{"given":"Artur","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"Pedro","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Jorge","family":"Pedrosa","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio G.","family":"Castro","sequence":"additional","affiliation":[]},{"given":"Rui M.","family":"Reis","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Baltazar","sequence":"additional","affiliation":[]},{"given":"Armando","family":"Almeida","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,3,28]]},"reference":[{"key":"185_CR1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.otc.2007.11.011","volume":"41","author":"JP Dworkin","year":"2008","unstructured":"Dworkin JP. Laryngitis: types, causes and treatments. Otolaryngol Clin North Am. 2008;41:419\u201336.","journal-title":"Otolaryngol Clin North Am"},{"key":"185_CR2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.otc.2007.11.012","volume":"41","author":"OE Tulunay","year":"2008","unstructured":"Tulunay OE. Laryngitis\u2014diagnosis and management. Otolaryngol Clin North Am. 2008;41:437\u201351.","journal-title":"Otolaryngol Clin North Am"},{"key":"185_CR3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1096\/fj.03-0645rev","volume":"18","author":"TD Warner","year":"2004","unstructured":"Warner TD, Mitchell JA. Cyclooxygenases: new forms, new inhibitors, and lessons from clinic. FASEB J. 2004;18:790\u2013804.","journal-title":"FASEB J"},{"key":"185_CR4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0889-1591(02)00021-1","volume":"16","author":"P Black","year":"2002","unstructured":"Black P. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun. 2002;16:622\u201353.","journal-title":"Brain Behav Immun"},{"key":"185_CR5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/jcp.20061","volume":"201","author":"M O\u2019Connor","year":"2004","unstructured":"O\u2019Connor M, O\u2019Connell J, O\u2019Brien I, Goode T, Bredin P, Shanahan F. The role of Substance P in inflammatory disease. J Cell Physiol. 2004;201:167\u201380.","journal-title":"J Cell Physiol"},{"key":"185_CR6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0090-1229(92)90053-Q","volume":"64","author":"V Weinstock","year":"1992","unstructured":"Weinstock V. Neuropeptides and the regulation of granulomatous inflammation. Clin Immun Immunopathol. 1992;64:17\u201322.","journal-title":"Clin Immun Immunopathol"},{"key":"185_CR7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/oxfordjournals.bmb.a072189","volume":"43","author":"C Foreman","year":"1987","unstructured":"Foreman C. Peptides and neurogenic inflammation. Br Med Bull. 1987;43:386\u2013400.","journal-title":"Br Med Bull"},{"key":"185_CR8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1124\/jpet.102.032797","volume":"302","author":"JD Richardson","year":"2000","unstructured":"Richardson JD, Vasko MR. Cellular mechanisms of neurogenic inflammation. J Pharm Exp Therap. 2000;302:839\u201345.","journal-title":"J Pharm Exp Therap"},{"key":"185_CR9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/MLG.0b013e3181492400","volume":"118","author":"M Lima-Rodrigues","year":"2008","unstructured":"Lima-Rodrigues M, Valle-Fernandes A, Lamas N, Cruz A, Baltazar F, Milanezi F, et al. A new model of Laryngitis: neuropeptide, COX and cytokine profile. Laryngoscope. 2008;118:78\u201386.","journal-title":"Laryngoscope"},{"key":"185_CR10","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1097\/00005537-200406000-00022","volume":"114","author":"M Lima-Rodrigues","year":"2004","unstructured":"Lima-Rodrigues M, Nunes R, Almeida A. Intraepithelial nerve fibers project into the lumen of the larynx. Laryngoscope. 2004;114:1074\u20137.","journal-title":"Laryngoscope"},{"key":"185_CR11","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1177\/000348948109000511","volume":"90","author":"M Friedman","year":"1981","unstructured":"Friedman M, Baim H, Shelton V, Stobnicki M, Chilis T, Ferrara T, et al. Laryngeal injuries secondary to nasogastric tubes. Ann Otol Rhinol Laryngol. 1981;90:469\u201374.","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"185_CR12","first-page":"327","volume":"6","author":"GF Gomes","year":"2003","unstructured":"Gomes GF, Pisani JC, Macedo ED, Campos AC. The nasogastric feeding tube as a risk factor for aspiration pneumonia. Curr Opi Clin Nutri Metab Care. 2003;6:327\u201333.","journal-title":"Curr Opi Clin Nutri Metab Care"},{"key":"185_CR13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJM200108093450607","volume":"345","author":"A Fitzgerald","year":"2001","unstructured":"Fitzgerald A, Patrono C. The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med. 2001;345:433\u201342.","journal-title":"N Engl J Med"},{"key":"185_CR14","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","volume":"354","author":"P Emery","year":"1999","unstructured":"Emery P, Zeidler H, Kvien TK, Guslandi M, Naudin R, Stead H, et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomized double-bind comparison. Lancet. 1999;354:2106\u201311.","journal-title":"Lancet"},{"key":"185_CR15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s000110050605","volume":"49","author":"M Katori","year":"2000","unstructured":"Katori M, Majima M. Cyclooxygenase-2: its rich diversity of roles and possible application of its selective inhibitors. Inflamm Res. 2000;49:367\u201392.","journal-title":"Inflamm Res"},{"key":"185_CR16","volume-title":"Goodman & Gilman\u2019s\u2014the pharmacological basis of therapeutics","author":"L Bruton","year":"2006","unstructured":"Bruton L, Laso S, Parker L. Goodman & Gilman\u2019s\u2014the pharmacological basis of therapeutics. 11th ed. Berlin: McGraw-Hill; 2006.","edition":"11"},{"key":"185_CR17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1177\/0091270007301621","volume":"47","author":"BP Schachtel","year":"2007","unstructured":"Schachtel BP, Pan S, Kohles JD, Sanner KM, Schachtel EP, Bey M. Utility and sensitivity of the sore throat pain model: results of a randomized controlled trial on the COX-2 selective inhibitor Valdecoxib. J Clin Pharmacol. 2007;47:860\u201370.","journal-title":"J Clin Pharmacol"},{"key":"185_CR18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/ar.1092310411","volume":"231","author":"MJ West","year":"1991","unstructured":"West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec. 1991;231:482\u201397.","journal-title":"Anat Rec"},{"key":"185_CR19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","volume":"193","author":"HJ Gundersen","year":"1999","unstructured":"Gundersen HJ, Jensen EB, Ki\u00eau K, Nielsen J. The efficiency of systematic sampling in stereology\u2014reconsidered. J Microsc. 1999;193:199\u2013211.","journal-title":"J Microsc"},{"key":"185_CR20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","volume":"8","author":"SA Khader","year":"2007","unstructured":"Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4\u00a0+\u00a0T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol. 2007;8:369\u201377.","journal-title":"Nat Immunol"},{"key":"185_CR21","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00403-007-0757-6","volume":"299","author":"TB Weberschock","year":"2007","unstructured":"Weberschock TB, M\u00fcller SM, Boehncke S, Boehncke WH. Tolerance to coxibs in patients with intolerance to non-steroidal anti-inflammatory drugs (NSAIDs): a systematic structured review of the literature. Arch Dermatol Res. 2007;299:169\u201375.","journal-title":"Arch Dermatol Res"},{"key":"185_CR22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2165\/00003495-199300461-00019","volume":"46","author":"A Ottaviani","year":"1993","unstructured":"Ottaviani A, Mantovani M, Scaricabarozzi I. A multicentre clinical study of nimesulide in inflammatory diseases of the ear, nose and throat. Drugs. 1993;46:96\u20139.","journal-title":"Drugs"},{"key":"185_CR23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003495-199300461-00021","volume":"46","author":"E Nouri","year":"1993","unstructured":"Nouri E, Monti T. Nimesulide granules for the treatment of acute inflammation of the ear, nose or throat. Drugs. 1993;46:103\u20136.","journal-title":"Drugs"},{"key":"185_CR24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1067\/mcp.2002.124079","volume":"71","author":"BP Schachtel","year":"2002","unstructured":"Schachtel BP, Homan HD, Gibb IA, Christian J. Demonstration of dose responde of flurbiprofen lozenges with the sore throat pain model. Clin Pharmacol Ther. 2002;71:375\u201380.","journal-title":"Clin Pharmacol Ther"},{"key":"185_CR25","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.2174\/0929867043363668","volume":"11","author":"W Kiefer","year":"2004","unstructured":"Kiefer W, Dannhardt G. Novel insights and therapeutical applications in the field of inhibitors of COX-2. Curr Med Chem. 2004;11:3147\u201361.","journal-title":"Curr Med Chem"},{"key":"185_CR26","doi-asserted-by":"crossref","first-page":"6289","DOI":"10.1523\/JNEUROSCI.20-16-06289.2000","volume":"20","author":"A Opr\u00e9e","year":"2000","unstructured":"Opr\u00e9e A, Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci. 2000;20:6289\u201393.","journal-title":"J Neurosci"},{"key":"185_CR27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.gassur.2003.11.023","volume":"8","author":"MI Slogoff","year":"2004","unstructured":"Slogoff MI, Ethridge RT, Rajaraman S, Evers BM. COX-2 inhibition results in alterations in nuclear factor (NF)-\u03baB activation but not cytokine production in acute pancreatitis. J Gastrointest Surg. 2004;8:511\u20139.","journal-title":"J Gastrointest Surg"},{"key":"185_CR28","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00428-004-1105-2","volume":"445","author":"D Wendum","year":"2004","unstructured":"Wendum D, Masliah J, Trugnan G, Fl\u00e9jou JF. Cyclooxygenase-2 and its role in colorectal cancer development. Virchows Arch. 2004;445:327\u201333.","journal-title":"Virchows Arch"},{"key":"185_CR29","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/01.HYP.35.1.373","volume":"35","author":"UC Kopp","year":"2000","unstructured":"Kopp UC, Cicha MZ, Smith LA, Haeggstr\u00f6m JZ, Samuelsson B, H\u00f6kfelt T. Cyclooxygenase-2 involved in stimulation of renal mechanosensitive neurons. Hypertension. 2000;35:373\u20138.","journal-title":"Hypertension"},{"key":"185_CR30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1006\/jsre.2001.6154","volume":"98","author":"VE Mack Strong","year":"2001","unstructured":"Mack Strong VE, Mackrell PJ, Concannon EM, Mestre JR, Smyth GP, Schaefer PA, et al. NS-398 treatment after trauma modifies NF-kappa B activation and improves survival. J Surg Res. 2001;98:40\u20136.","journal-title":"J Surg Res"},{"key":"185_CR31","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1158\/1078-0432.CCR-06-2221","volume":"13","author":"C Waes Van","year":"2007","unstructured":"Van Waes C. Nuclear factor-\u03baB in development, prevention and therapy of cancer. Clin Cancer Res. 2007;13:1076\u201382.","journal-title":"Clin Cancer Res"},{"key":"185_CR32","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.165.10.5606","volume":"165","author":"BL Fiebich","year":"2000","unstructured":"Fiebich BL, Schleicher S, Butcher RD, Craig A, Lieb K. The neuropeptide Substance P activates p38 mitogen-activated protein kinase resulting in IL-6 expression independently from NF-kappa B. J Immunol. 2000;165:5606\u201311.","journal-title":"J Immunol"},{"key":"185_CR33","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1096\/fj.01-0390rev","volume":"15","author":"I Tegeder","year":"2001","unstructured":"Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 2001;15:2057\u201372.","journal-title":"FASEB J"},{"key":"185_CR34","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.0300-9475.2004.01481.x","volume":"60","author":"C H\u00e4rtel","year":"2004","unstructured":"H\u00e4rtel C, von Puttkamer J, Gallner F, Strunk T, Schultz C. Dose-dependent immunomodulatory effects of acetylsalicylic acid and indomethacin in human whole blood: potential role of cyclooxygenase-2 inhibition. Scand J Immunol. 2004;60:412\u201320.","journal-title":"Scand J Immunol"},{"key":"185_CR35","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","volume":"19","author":"KW Moore","year":"2001","unstructured":"Moore KW, de Waal Malefyt R, Coffman RL, O\u2019Garra A. Interleukin-10 and the Interleukin-10 Receptor. Ann Rev Immun. 2001;19:683\u2013765.","journal-title":"Ann Rev Immun"},{"key":"185_CR36","first-page":"225","volume":"158","author":"MJ Toebak","year":"2008","unstructured":"Toebak MJ, de Rooij J, Moed H, Stoof TJ, von Blomberg BM, Bruynzeel DP, et al. Differential suppression of dendritic cell cytokine production by anti-inflammatory drugs. Br J Dermatol. 2008;158:225\u201333.","journal-title":"Br J Dermatol"},{"key":"185_CR37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2003.12.015","volume":"486","author":"Z Warzecha","year":"2004","unstructured":"Warzecha Z, Dembi\u0144ski A, Ceranowicz P, Konturek S, Tomaszewska S, Stachura J, et al. Inhibition of cyclooxygenase-2 reduces the protective effect of hepatocyte growth factor in experimental pancreatitis. Eur J Pharmacol. 2004;486:107\u201319.","journal-title":"Eur J Pharmacol"},{"key":"185_CR38","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1177\/00220345000790081301","volume":"79","author":"HE Goodis","year":"2000","unstructured":"Goodis HE, Bowles WR, Hargreaves KM. Prostaglandin E2 enhances bradykinin-evoked iCGRP release in bovine dental pulp. J Dent Res. 2000;79:1604\u20137.","journal-title":"J Dent Res"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-010-0185-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-010-0185-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-010-0185-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T09:49:14Z","timestamp":1558518554000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-010-0185-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,28]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["185"],"URL":"https:\/\/doi.org\/10.1007\/s00011-010-0185-5","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,28]]}}}